Johnson & Johnson, AstraZeneca plc, and other Covid-19 vaccine makers are shielded from liability for adverse effects on recipients, and attorneys say the protections are a boon for medical innovation that’s critical to combating the pandemic.
A vaccine advisory panel for the Centers for Disease Control and Prevention met on Wednesday to discuss how to move forward with the J&J vaccine after seven women developed rare and dangerous blood clots following their shots. The CDC’s Advisory Committee on Immunization Practices didn’t make a recommendation and said it will find a time to reconvene—leaving the vaccine on pause.
U.S. ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.